Anesth Analg: Aspirin can reduce the risk of death in coVID-19 hospitalized patients, according to new research.

More than 100 years after its invention, Aspirin has now entered thousands of homes as an anti-heat analgesant.
Surprisingly, scientists have unexpectedly discovered in recent years that aspirin is far more effective than that, and a growing body of research shows that aspirin also has some preventive and therapeutic effects on major diseases such as neurodegenerative diseases and cancer.
October 21, 2020, researchers at the University of Maryland School of Medicine published a research paper entitled: Aspirin Use Is Associated with Withd Mechanical Developmenton, ICU Admission, and In-Hospital City In Hospitaled Patients with COVID-19.
study found that in hospitalized patients with COVID-19, patients who took low-dose aspirin daily to prevent cardiovascular disease had a significantly lower risk of complications and death than those who did not.
foreshadows that aspirin will be a safe, effective and inexpensive new coronary preventive drug.
Today, the new crown outbreak shows no sign of abating, and even more frightening is the fact that in recent days, as the northern hemisphere has gradually entered the autumn and winter season, outbreaks in Europe and other regions have rebounded again, while the situation in countries such as the United States, India and Brazil has not improved.
from this point of view, the fight against the new crown epidemic is bound to be a long-lasting war, so the development of some safe, effective and inexpensive new crown prevention and treatment programs is necessary.
the study, the team first screened the medical records of 412 COVID-19 hospitalized patients, with an average age of 55, who had been hospitalized for complications of infection in the past few months.
note that about a quarter of patients take low doses of aspirin (usually 81 mg) daily before and after hospitalization to prevent and control cardiovascular disease.
medical records of 412 COVID-19 hospitalized patients found that taking low-dose aspirin daily effectively reduced the risk of using a ventilator by 44 percent and by 43 percent in the ICU compared to patients who did not take aspirin.
, the risk of hospitalization was reduced by 47%, and the rate of adverse events such as haemorrhage did not increase significantly.
Taking low doses of aspirin daily could significantly reduce the fertility rate of COVID-19 patients, and the researchers controlled for several factors that may play a role in the patient's prognosis, including age, gender, body mass index, race, hypertension, and diabetes.
, heart disease, kidney disease, liver disease, and the use of blockers to control blood pressure are also associated with these diseases.
compared to patients who did not take aspirin, why is taking aspirin effective in reducing the rate of severe conversion in patients with COVID-19? In fact, COVID-19 infections increase thrombosis in the heart, lungs, blood vessels, and other organs, and in rare cases complications from thrombosis can lead to heart attacks, strokes, multiple organ failure, and even death.
at the same time, clinically, doctors often advise patients who have had a heart attack or stroke caused by a blood clot to take low-dose aspirin daily to prevent future blood clots.
, taking aspirin daily also increases the risk of haemorrhage or peptic ulcer disease.
Nature News reports that "the mystery of blood clotting in patients with severe COVID-19 has forced the development of new therapies" "We believe that aspirin can prevent the formation of tiny blood clots, thus providing unexpected benefits for COVID-19 patients," said Michael A. A., associate professor of anesthesiology at UMSOM University. Dr Mazzeffi said: "Patients diagnosed with COVID-19 may consider taking aspirin daily as long as they check with their doctor first.
, "of course, not all COVID-19 patients can use the therapy.
for example, people who are at increased risk of bleeding from chronic kidney disease, or because they regularly use certain medications, such as steroids or blood thinners, may not be able to safely take aspirin.
but in any case, this is a critical finding and deserves further randomized clinical trials to confirm.
, the paper's lead author, Dr Jonathan Chow, said: "If our findings are confirmed, it will make aspirin the first widely used over-the-counter drug to reduce mortality in COVID-19 patients.
"